CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.010
-0.040 (-3.81%)
Nov 4, 2024, 4:00 PM EST - Market closed

CytomX Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
43.2517.17193.65205.53191.86188.43
Upgrade
Short-Term Investments
93.94157.34-99.7124.26107.72
Upgrade
Cash & Short-Term Investments
137.18174.51193.65305.23316.12296.15
Upgrade
Cash Growth
-24.15%-9.88%-36.56%-3.45%6.74%-32.10%
Upgrade
Receivables
2.783.4335.990.790.80.01
Upgrade
Prepaid Expenses
3.1257.474.297.17.18
Upgrade
Total Current Assets
143.08182.94237.1310.3324.01303.34
Upgrade
Property, Plant & Equipment
13.5416.1821.0225.3229.4532.75
Upgrade
Goodwill
0.950.950.950.950.950.95
Upgrade
Other Intangible Assets
0.660.730.881.021.171.31
Upgrade
Other Long-Term Assets
0.9910.941.823.092.93
Upgrade
Total Assets
159.22201.79260.89339.41358.66341.28
Upgrade
Accounts Payable
0.611.462.812.8234.16
Upgrade
Accrued Expenses
13.6217.622.8230.6219.8627.24
Upgrade
Current Portion of Leases
4.864.594.083.623.22.81
Upgrade
Current Unearned Revenue
123.77132.27121.2740.8242.0651.38
Upgrade
Other Current Liabilities
--1.63---
Upgrade
Total Current Liabilities
142.86155.91152.6177.8768.1185.59
Upgrade
Long-Term Leases
6.899.3913.9818.0621.6824.87
Upgrade
Long-Term Unearned Revenue
36.7180.05180.06243.94276.65178.86
Upgrade
Other Long-Term Liabilities
3.993.89---0.85
Upgrade
Total Liabilities
190.45249.24346.64339.87366.44290.17
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
684.97675.91637.12623.34499.96468.29
Upgrade
Retained Earnings
-716.19-723.45-722.88-623.56-507.69-417.23
Upgrade
Comprehensive Income & Other
-00.10.01-0.24-0.050.06
Upgrade
Total Common Equity
-31.23-47.45-85.75-0.46-7.7751.11
Upgrade
Shareholders' Equity
-31.23-47.45-85.75-0.46-7.7751.11
Upgrade
Total Liabilities & Equity
159.22201.79260.89339.41358.66341.28
Upgrade
Total Debt
11.7513.9718.0621.6724.8727.68
Upgrade
Net Cash (Debt)
125.44160.54175.59283.55291.25268.46
Upgrade
Net Cash Growth
-23.88%-8.58%-38.07%-2.64%8.49%-38.44%
Upgrade
Net Cash Per Share
1.522.182.674.426.315.92
Upgrade
Filing Date Shares Outstanding
78.1267.7266.2365.3964.7845.57
Upgrade
Total Common Shares Outstanding
78.1267.3166.2365.3948.2545.52
Upgrade
Working Capital
0.2227.0284.49232.43255.9217.75
Upgrade
Book Value Per Share
-0.40-0.70-1.29-0.01-0.161.12
Upgrade
Tangible Book Value
-32.83-49.13-87.58-2.43-9.8948.85
Upgrade
Tangible Book Value Per Share
-0.42-0.73-1.32-0.04-0.201.07
Upgrade
Machinery
-16.31717.7516.414.7
Upgrade
Construction In Progress
-0.370.710.310.250.24
Upgrade
Leasehold Improvements
-1.981.741.741.731.48
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.